12. Where—
(a)animals are used in the production of any medicinal products; and
(b)relevant marketing authorizations contain provisions relating to them,
the manufacturer’s licence holder shall arrange for those animals to be housed in premises of such a nature, and be managed in such a manner as to facilitate compliance with such provisions.